Cancer Genetics, Inc. Listed by Merck as a National Reference Laboratory for KEYTRUDA® (pembrolizumab) Companion Diagnostic ...
Reinforces CGI’s Position as a Leader in Immuno-Oncology & Companion Diagnostics For PD-L1 Testing & Monitoring Company Expects Significant Growth in Comprehensive Molecular & Immune Profiling for Lung Cancer as KEYTRUDA Enters First-Line …